YM-53601 |
YM-53601 |
182959-33-7 |
pyridine-3-sulfonyl chloride |
吡啶-3-磺酰氯 |
16133-25-8 |
8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid |
咪达唑仑杂质 |
59468-44-9 |
Argireline |
阿基瑞林 |
616204-22-9 |
(R)-4-Propyldihydrofuran-2(3H)-one |
布瓦西坦中间体1 |
63095-51-2 |
Pyrrolo[3,4-c]pyrrole, 2-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-1,2,3,4,5,6-hexahydro- |
Pyrrolo[3,4-c]pyrrole, 2-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-1,2,3,4,5,6-hexahydro- |
2245054-23-1 |
Pyrrolo[3,4-c]pyrrole-2(1H)-carboxylic acid, 5-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-3,4,5,6-tetrahydro-, 1,1-dimethylethyl ester |
Pyrrolo[3,4-c]pyrrole-2(1H)-carboxylic acid, 5-[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]-3,4,5,6-tetrahydro-, 1,1-dimethylethyl ester |
2245054-22-0 |
3-(7-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
3-(7-氟-1-氧代异吲哚-2-基)哌啶-2,6-二酮 |
2287267-33-6 |
Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 5'-hydroxy-2'-(methylthio)-6'-oxo-, 1,1-dimethylethyl ester |
Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 5'-hydroxy-2'-(methylthio)-6'-oxo-, 1,1-dimethylethyl ester |
2170746-97-9 |
MLS1547 |
5-CHLORO-7-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-8-QUINOLINOL |
315698-36-3 |
1-ethylcyclopentyl ester |
1-乙基环戊基甲基丙烯酸酯 |
266308-58-1 |
1,3-Adamantanediol monomethacrylate |
1,3-单丙烯酸金刚烷醇 |
216581-76-9 |
(R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine |
(R)-(+)-8-METHYL-5-(3-METHYL-4-NITROPHENYL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]BENZODIAZEPINE |
732277-05-3 |
allyl 3-methoxymorpholine-4-carboxylate |
3-甲氧基吗啉-4-羧酸烯丙酯 |
2119729-43-8 |
Glenzocimab |
GLENZOCIMAB (格仑西单抗 ) |
2101829-58-5 |
Relfovetmab |
RELFOVETMAB (瑞弗维单抗 ) |
2171034-70-9 |
Disitamab |
DISITAMAB (迪西妥单抗 ) |
2185868-98-6 |
Budigalimab |
Budigalimab |
2098225-93-3 |
Amatuximab |
阿麦妥单抗 |
931402-35-6 |
Iladatuzumab |
Iladatuzumab |
1906205-76-2 |